Skip to main content
. 2019 Sep 4;14(9):e0221568. doi: 10.1371/journal.pone.0221568

Fig 4.

Fig 4

Hazard characterisation for (A) macrolide and (B) fluoroquinolone resistance selection after a reduction of 77% and 85% in prescriptions, respectively, on 2015/16 rates. Red circles in (A) indicate nine locations where the concentrations remained ‘at critical’ levels.